AU1218892A - Pharmaceutical aerosol formulations - Google Patents

Pharmaceutical aerosol formulations

Info

Publication number
AU1218892A
AU1218892A AU12188/92A AU1218892A AU1218892A AU 1218892 A AU1218892 A AU 1218892A AU 12188/92 A AU12188/92 A AU 12188/92A AU 1218892 A AU1218892 A AU 1218892A AU 1218892 A AU1218892 A AU 1218892A
Authority
AU
Australia
Prior art keywords
aerosol formulations
pharmaceutical aerosol
pharmaceutical
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12188/92A
Other versions
AU646723B2 (en
Inventor
Kurt Herzog
Manfred Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAGO PHARMA AG
Ciba Geigy AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH78191 priority Critical
Priority to CH781/91 priority
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU1218892A publication Critical patent/AU1218892A/en
Application granted granted Critical
Publication of AU646723B2 publication Critical patent/AU646723B2/en
Anticipated expiration legal-status Critical
Application status is Ceased legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
AU12188/92A 1991-03-14 1992-03-10 Pharmaceutical aerosol formulations Ceased AU646723B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH78191 1991-03-14
CH781/91 1991-03-14

Publications (2)

Publication Number Publication Date
AU1218892A true AU1218892A (en) 1992-09-17
AU646723B2 AU646723B2 (en) 1994-03-03

Family

ID=4195038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12188/92A Ceased AU646723B2 (en) 1991-03-14 1992-03-10 Pharmaceutical aerosol formulations

Country Status (12)

Country Link
EP (1) EP0504112A3 (en)
JP (1) JPH04327527A (en)
AU (1) AU646723B2 (en)
CA (1) CA2062854A1 (en)
FI (1) FI921060A (en)
HU (1) HU208398B (en)
IE (1) IE920826A1 (en)
IL (1) IL101169D0 (en)
MX (1) MX9201082A (en)
NO (1) NO920987L (en)
NZ (1) NZ241938A (en)
ZA (1) ZA9201877B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (en) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg New propellant gases and their use in drug preparations
MX9203481A (en) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulations.
DE69231991D1 (en) 1991-06-10 2001-09-13 Schering Corp Chlorofluorocarbons Hydrogen-free aerosol formulations
DE4123663A1 (en) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Medicinal aerosol free from fluoro:chlorocarbon(s) - contains active agent in suspending or dispersing aid and alcohol with hepta:fluoro:propane as propellant
DE4132176C2 (en) * 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh MDIs containing isobutane as a propellant
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
CA2125665C (en) * 1991-12-12 2001-06-12 Rachel Ann Akehurst Medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
AT171865T (en) 1991-12-12 1998-10-15 Glaxo Group Ltd drug
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DK1086688T3 (en) 1991-12-18 2004-08-16 Minnesota Mining & Mfg Aerosol formulations for suspensions
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
DK0550031T3 (en) * 1991-12-31 1996-08-26 Solvay medical aerosol formulation
JP3009924B2 (en) * 1992-12-09 2000-02-14 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Stabilization medical aerosols solution formulation
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
AT183919T (en) * 1993-03-29 1999-09-15 Lynchris Pharm Ltd Anesthetic in aerosol form on the basis of lidocaine
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Drug preparations of coated, heavy water-soluble drugs for inhalation dosage forms and methods for their preparation
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
CA2183557A1 (en) * 1994-03-14 1995-09-21 Mou-Ying Fu Lu Aerosol drug formulations containing vitamin e
HU219900B (en) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Metered dose inhaler
BR9604977A (en) 1995-04-14 1998-06-09 Glaxo Wellcome Inc metered dose inhaler a metered dose inhaler system and use thereof
DE69636757T2 (en) 1995-04-14 2007-10-11 Smithkline Beecham Corp. Metered dose inhaler for Fluticasonepropionat
PL180880B1 (en) 1995-04-14 2001-04-30 Glaxo Wellcome Inc. Beclomethasone inhaler with dosis metering feature
PL186196B1 (en) 1995-06-27 2003-11-28 Boehringer Ingelheim Kg Novel stable preparations of therapeutic agents for obtaining aerosols without gaseous propellant
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
GB9620187D0 (en) 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
AT219355T (en) 1997-02-05 2002-07-15 Jago Res Ag Medical aerosol formulations
WO1998037894A1 (en) * 1997-02-28 1998-09-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP1036561A1 (en) * 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
AU1594099A (en) * 1997-11-18 1999-06-07 Allied-Signal Inc. Hydrofluorocarbon refrigerants
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
AU748867B2 (en) 1998-07-24 2002-06-13 Jagotec Ag Medicinal aerosol formulations
ES2193726T3 (en) 1998-08-04 2003-11-01 Jago Res Ag Medicinal aerosol formulations.
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa pressurized meter dose inhaler.
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
DE19911064A1 (en) * 1999-03-12 2000-09-14 Ig Spruehtechnik Gmbh MDIs containing isobutane as a propellant
DE19921693A1 (en) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa New quinuclidine derivatives and pharmaceutical compositions containing them.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulations optimized consist of dasomministrare steroids solutions for inhalation.
IT1313567B1 (en) * 1999-07-27 2002-09-09 Zambon Spa Use of n-acetyl-cysteine ​​for the preparation of topical composizionifarmaceutiche for the treatment of allergic diseases of the
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulations containing an anticholinergic drug for chronic obstructive pulmonary disease trattamentodella.
HU230804B1 (en) 2000-05-22 2018-06-28 Chiesi Farm Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
WO2002036106A2 (en) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions based on anticholinergics and corticosteroids
ME00242B (en) * 2000-10-31 2011-05-10 Boehringer Ingelheim Pharma Inhalative solution formulation containing a tiotropium salt
DE10062712A1 (en) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma New pharmaceutical compositions based on anticholinergics and corticosteroids
ES2222294T3 (en) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Optimized formulation for tobramycin aerosol administration.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
JP4828405B2 (en) * 2003-02-10 2011-11-30 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフトBayer Schering Pharma Aktiengesellschaft Treatment of bacterial diseases of the respiratory organs
AU2004246819A1 (en) 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP2425819A1 (en) 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8444873B2 (en) 2009-06-12 2013-05-21 Solvay Fluor Gmbh Refrigerant composition
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (en) * 1976-08-13 1978-02-15 Montedison Spa A process for the preparation of new propellant compositions for aerosols.
SE8505048L (en) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Nutrition emulsion with oxygen transport properties
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680967B2 (en) * 1993-12-20 1997-08-14 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
US5776433A (en) * 1993-12-20 1998-07-07 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations

Also Published As

Publication number Publication date
FI921060D0 (en)
IL101169D0 (en) 1992-11-15
EP0504112A2 (en) 1992-09-16
MX9201082A (en) 1992-09-01
JPH04327527A (en) 1992-11-17
HUT60430A (en) 1992-09-28
ZA9201877B (en) 1992-10-28
FI921060A0 (en) 1992-03-11
CA2062854A1 (en) 1992-09-15
HU208398B (en) 1993-10-28
EP0504112A3 (en) 1993-04-21
AU646723B2 (en) 1994-03-03
FI921060A (en) 1992-09-15
HU9200850D0 (en) 1992-05-28
NO920987D0 (en) 1992-03-13
NO920987L (en) 1992-09-15
NZ241938A (en) 1993-06-25
IE920826A1 (en) 1992-09-23

Similar Documents

Publication Publication Date Title
AU655187B2 (en) Continuous release pharmaceutical compositions
AU656157B2 (en) Pharmaceutical agents
EG22373A (en) New pharmaceutical formulation
EG23826A (en) Pharmaceutical formulations
AU635021B2 (en) Extended release pharmaceutical formulations
AU663904C (en) Medicaments
AU663906C (en) Medicaments
AU660952B2 (en) Aerosol medicaments
GB8828477D0 (en) Medical aerosol formulations
ZA8907437B (en) Pharmaceutical formulations
IL104628A (en) Aerosol pharmaceutical composition comprising beclomethasone-17, 21-dipropionate
GB9408117D0 (en) Pharmaceutical formulations
GR3036467T3 (en) Suspension aerosol formulations
AU7722994A (en) Pharmaceutical composition
AU2154492A (en) Magnetically influenced homeopathic pharmaceutical formulations
AU6883994A (en) Pharmaceutical composition
AU653369B2 (en) Aerosol containing medicaments
ZA9300234B (en) Flavour-masked pharmaceutical compositions
AU1611492A (en) Aerosol inhalation device
GR3019374T3 (en) Non-chlorofluorocarbon aerosol formulations
IL102130D0 (en) Non-chlorofluorocarbon aerosol formulations
AU3604893A (en) Aerosol extension
SK19495A3 (en) Pharmaceutical compositions
IL101795A (en) Pharmaceutical tablet formulations
AU3492789A (en) Pharmaceutical compositions